Chemed Corp (CHE)

Currency in USD
435.35
+0.44(+0.10%)
Real-time Data·
CHE Scorecard
Full Analysis
Management has been aggressively buying back shares
CHE is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
434.11437.85
52 wk Range
408.42623.61
Key Statistics
Prev. Close
434.91
Open
434.9
Day's Range
434.11-437.85
52 wk Range
408.42-623.61
Volume
36.85K
Average Volume (3m)
163.21K
1-Year Change
-23.53%
Book Value / Share
82.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CHE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
567.25
Upside
+30.30%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 16 consecutive years

Chemed Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Chemed Corp Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Corp Earnings Call Summary for Q2/2025

  • Q2 2025 EPS at $4.27, missing $5.39 forecast; revenue at $618.8M vs $650.6M expected; stock drops 8.8% after-hours
  • Full-year EPS guidance revised down to $22.00-$22.30 from $24.95-$25.45; VITAS revenue up 5.8% YoY, Roto Rooter EBITDA down 18.7%
  • CEO emphasizes focus on acquisitions and managing Medicare cap issues; CFO seeks 'right valuation' acquisitions
  • Challenges: hospice market competition, digital ad changes affecting Roto Rooter, COVID-19 demographic shifts, private equity competition
  • Company maintains strong financial health score of 3.05/5, with robust cash flows and conservative debt-to-equity ratio of 0.12
Last Updated: 30/07/2025, 18:08
Read Full Transcript

Compare CHE to Peers and Sector

Metrics to compare
CHE
Peers
Sector
Relationship
P/E Ratio
21.7x26.8x−0.5x
PEG Ratio
−17.661.820.00
Price/Book
5.3x3.0x2.6x
Price / LTM Sales
2.5x0.9x3.3x
Upside (Analyst Target)
34.4%20.4%43.4%
Fair Value Upside
Unlock−0.9%7.1%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 567.25
(+30.30% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 19.65%
Dividend Yield
0.55%
Industry Median 2.52%
Annualised payout
2.40
Paid quarterly
5-Years Growth
+9.34%
Growth Streak

Earnings

Latest Release
Jul 29, 2025
EPS / Forecast
4.27 / 5.39
Revenue / Forecast
618.80M / 650.60M
EPS Revisions
Last 90 days

CHE Income Statement

People Also Watch

26.62
SPNS
+0.49%
56.50
NXT
+1.40%
32.15
YOU
+0.69%
37.65
EXEL
+0.70%
179.02
IQV
+0.04%

FAQ

What Stock Exchange Does Chemed Trade On?

Chemed is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Chemed?

The stock symbol for Chemed is "CHE."

What Is the Chemed Market Cap?

As of today, Chemed market cap is 6.33B.

What Is Chemed's Earnings Per Share (TTM)?

The Chemed EPS (TTM) is 19.65.

When Is the Next Chemed Earnings Date?

Chemed will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is CHE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Chemed Stock Split?

Chemed has split 2 times.

How Many Employees Does Chemed Have?

Chemed has 15695 employees.

What is the current trading status of Chemed (CHE)?

As of 08 Aug 2025, Chemed (CHE) is trading at a price of 435.35, with a previous close of 434.91. The stock has fluctuated within a day range of 434.11 to 437.85, while its 52-week range spans from 408.42 to 623.61.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.